| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $500K | -96.9% |
| R&D Expense | $8.6M | +11.6% |
| SG&A Expense | $4.1M | -23.8% |
| Operating Income | -$12.1M | -485.3% |
| Interest Expense | $27K | -86.7% |
| Pre-tax Income | -$10.8M | -1596.3% |
| Income Tax | $681 | +240.5% |
| Net Income | -$10.8M | -1595.9% |
| EPS (Basic) | -$0.12 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.1M | +6.7% |
| Current Assets | $34.1M | -26.4% |
| Total Assets | $37.5M | -28.5% |
| Current Liabilities | $1.7M | -70.1% |
| Total Liabilities | $1.9M | -72.4% |
| Stockholders' Equity | $35.6M | -21.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.0M | -171.3% |
| Capital Expenditures | $134K | +1663.0% |
| Investing Cash Flow | $14.3M | +132.6% |
| Financing Cash Flow | -$2.1M | -107.9% |
| Free Cash Flow | -$12.1M | -173.9% |
| -1100.0% |
| EPS (Diluted) | -$0.13 | -1200.0% |